Literature DB >> 25319693

Resting-state functional connectivity changes in aging apoE4 and apoE-KO mice.

Valerio Zerbi1, Maximilian Wiesmann2, Tim L Emmerzaal3, Diane Jansen3, Maarten Van Beek3, Martina P C Mutsaers3, Christian F Beckmann4, Arend Heerschap5, Amanda J Kiliaan6.   

Abstract

It is well established that the cholesterol-transporter apolipoprotein ε (APOE) genotype is associated with the risk of developing neurodegenerative diseases. Recently, brain functional connectivity (FC) in apoE-ε4 carriers has been investigated by means of resting-state fMRI, showing a marked differentiation in several functional networks at different ages compared with carriers of other apoE isoforms. The causes of such hampered FC are not understood. We hypothesize that vascular function and synaptic repair processes, which are both impaired in carriers of ε4, are the major contributors to the loss of FC during aging. To test this hypothesis, we integrated several different MRI techniques with immunohistochemistry and investigated FC changes in relation with perfusion, diffusion, and synaptic density in apoE4 and apoE-knock-out (KO) mice at 12 (adult) and 18 months of age. Compared with wild-type mice, we detected FC deficits in both adult and old apoE4 and apoE-KO mice. In apoE4 mice, these changes occurred concomitant with increased mean diffusivity in the hippocampus, whereas perfusion deficits appear only later in life, together with reduced postsynaptic density levels. Instead, in apoE-KO mice FC deficits were mirrored by strongly reduced brain perfusion since adulthood. In conclusion, we provide new evidence for a relation between apoE and brain connectivity, possibly mediated by vascular risk factors and by the efficiency of APOE as synaptic modulator in the brain. Our results show that multimodal MR neuroimaging is an excellent tool to assess brain function and to investigate early neuropathology and aging effects in translational research.
Copyright © 2014 the authors 0270-6474/14/3413963-13$15.00/0.

Entities:  

Keywords:  apoE; apoE4 mice; cerebral blood flow; diffusion tensor imaging; functional connectivity; resting-state fMRI

Mesh:

Substances:

Year:  2014        PMID: 25319693      PMCID: PMC6705289          DOI: 10.1523/JNEUROSCI.0684-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

1.  Common functional networks in the mouse brain revealed by multi-centre resting-state fMRI analysis.

Authors:  Joanes Grandjean; Carola Canella; Cynthia Anckaerts; Gülebru Ayrancı; Salma Bougacha; Thomas Bienert; David Buehlmann; Ludovico Coletta; Daniel Gallino; Natalia Gass; Clément M Garin; Nachiket Abhay Nadkarni; Neele S Hübner; Meltem Karatas; Yuji Komaki; Silke Kreitz; Francesca Mandino; Anna E Mechling; Chika Sato; Katja Sauer; Disha Shah; Sandra Strobelt; Norio Takata; Isabel Wank; Tong Wu; Noriaki Yahata; Ling Yun Yeow; Yohan Yee; Ichio Aoki; M Mallar Chakravarty; Wei-Tang Chang; Marc Dhenain; Dominik von Elverfeldt; Laura-Adela Harsan; Andreas Hess; Tianzi Jiang; Georgios A Keliris; Jason P Lerch; Andreas Meyer-Lindenberg; Hideyuki Okano; Markus Rudin; Alexander Sartorius; Annemie Van der Linden; Marleen Verhoye; Wolfgang Weber-Fahr; Nicole Wenderoth; Valerio Zerbi; Alessandro Gozzi
Journal:  Neuroimage       Date:  2019-10-12       Impact factor: 6.556

2.  Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome.

Authors:  Anna E Mechling; Tanzil Arefin; Hsu-Lei Lee; Thomas Bienert; Marco Reisert; Sami Ben Hamida; Emmanuel Darcq; Aliza Ehrlich; Claire Gaveriaux-Ruff; Maxime J Parent; Pedro Rosa-Neto; Jürgen Hennig; Dominik von Elverfeldt; Brigitte Lina Kieffer; Laura-Adela Harsan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

3.  Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.

Authors:  Maximilian Wiesmann; Monica Roelofs; Robert van der Lugt; Arend Heerschap; Amanda J Kiliaan; Jurgen Ahr Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice.

Authors:  I A C Arnoldussen; M Wiesmann; C E Pelgrim; E M Wielemaker; W van Duyvenvoorde; P L Amaral-Santos; L Verschuren; B J F Keijser; A Heerschap; R Kleemann; P Y Wielinga; A J Kiliaan
Journal:  Int J Obes (Lond)       Date:  2017-02-21       Impact factor: 5.095

Review 5.  APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.

Authors:  Samira Parhizkar; David M Holtzman
Journal:  Semin Immunol       Date:  2022-02-26       Impact factor: 10.671

6.  Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice.

Authors:  Courtney Lane-Donovan; Wen Mai Wong; Murat S Durakoglugil; Catherine R Wasser; Shan Jiang; Xunde Xian; Joachim Herz
Journal:  J Neurosci       Date:  2016-09-28       Impact factor: 6.167

Review 7.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

8.  Evaluation of B0-correction of relative CBF maps using tagging distance dependent Z-spectrum (TADDZ).

Authors:  Frederick C Damen; Rong-Wen Tain; Riya Thomas; Weigo Li; Leon Tai; Kejia Cai
Journal:  Magn Reson Imaging       Date:  2019-10-25       Impact factor: 2.546

Review 9.  Exercise as Potential Therapeutic Target to Modulate Alzheimer's Disease Pathology in APOE ε4 Carriers: A Systematic Review.

Authors:  Sevilay Tokgöz; Jurgen A H R Claassen
Journal:  Cardiol Ther       Date:  2021-01-05

10.  Characterization of brain-wide somatosensory BOLD fMRI in mice under dexmedetomidine/isoflurane and ketamine/xylazine.

Authors:  Taeyi You; Geun Ho Im; Seong-Gi Kim
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.